H.R. 5160 explained · 119th Congress · Pending in Congress
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Cosponsors: 21 (11 D, 10 R) · per Congress.gov, 2026-10-14
Introduced: 2025-09-04
Latest action (2026-07-21): Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
What H.R. 5160 does, in plain terms
Stem Cell Therapeutic and Research Reauthorization Act of 2025 This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA). The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.
Official summary by the Congressional Research Service, via Congress.gov.
Constitution Index
“VFA Constitution grade”
Not graded yet
H.R. 5160 has not been graded yet. New measures with an official summary are graded daily under the published rubric.
What should pass
“VFA SI Solution”
Archived SI output (machine-generated) · No editorial review recorded
This historical draft has no editorial review time on record. Check its claims against the original bill and current law.
Stem Cell Therapeutic and Research Reauthorization Act of 2025 – Fiscal Responsibility and Sunset Version
Generated by VFA SI Solutions
Reauthorize federal funding for the National Cord Blood Inventory and the C.W. Bill Young Cell Transplantation Program to maintain and expand the availability of stem cell therapies for patients with blood cancers and other disorders.
Bipartisan rationale: Democratic priorities honored: continued federal investment in stem cell therapies for life-threatening diseases, maintaining access for underserved populations, and preserving the existing cord blood network. Republican priorities honored: spending cap reduction, sunset provision, prohibition on embryonic stem cell research (consistent with Dickey-Wicker), and enhanced oversight to prevent waste.
Report an error in this Solution
Citizen Consensus
“Do you support this VFA SI Solution?”
One vote per verified account; you can change it any time. Only verified accounts count, results publish once 30 verified people have voted, and state and district results count only people who attested a home ZIP code. How this works.
Email verification is not switched on yet, so no vote counts toward results yet. Votes cast now are saved and count once the voter verifies their email address.
Sign in or create a free account to vote.
Add a short reason (optional)
/280 · no links or contact details · reasons are reviewed before anyone sees them, and many never are shown.
Your vote is saved but held out of published results by an automated integrity check (for example, several accounts voting from one browser).
Your vote is saved. It will count once you verify your email address. Verify on your account page.
Your vote counts nationally. Add your home ZIP code to count in your state and district too.
Your vote counts nationally and in .
Reason saved privately; it is shown only if it passes review.
Verified participants nationwide · n =
Self-selected participants, not a random sample; ± is the 95% sampling margin.
Not enough verified votes yet. Results publish at verified votes.
A sudden surge of votes on this item was flagged and is under review; votes from new accounts in that surge are held out until it is resolved.
For journalists and bloggers
“Embed this grade”
Free to use with the link back. The badge and card update when the grade changes. Embed terms →
